Live
FierceBiotechMRD as a Decision Engine: Rethinking Oncology Trial Design from Early Phase to RegistrationClinical OMICsEndometriosis May Increase Risk of Birth DefectsBoston ScientificBoston Scientific (BSX) Valuation Check After New Atrial Fibrillation And Stroke Prevention Data - simplywall.stAgilentAgilent Taps Cirena To Turn Long RNA Technology Into Genome Editing Growth - Yahoo FinanceScience Daily BiotechScientists successfully transfer longevity gene and extend lifespanLonza NewsLonza says big pharma might delay outsourcing decisions amid US investments - MSNSiemens HealthineersSiemens Healthineers: Update Post The Carve-Out Announcement (OTCMKTS:SEMHF) - Seeking AlphaRecursionA Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates - simplywall.stSHINVA MEDICAL INSTRUMENT CO.,LTD.World Ampoule Filling And Sealing Machine - Market Analysis, Forecast, Size, Trends and Insights - IndexBox10x Genomics BlogWhy 10x Genomics (TXG) stock is down today - MSN10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.st10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.st
BioPharma Dive Mar 26, 2026

Merck’s deal for Terns sparks debate over a possible biotech bidding war

Merck’s deal for Terns sparks debate over a possible biotech bidding war

Original
Body unavailable. Use the original source.